CompletedNCT01614912
What is this study about?Researchers studied SM-13496 to find out how it affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Tokyo, EtcSchizophreniaMedication studyAges 18–74
- Countries
- Japan, Malaysia, South Korea, + 1 other
- Sponsor
- Sumitomo Pharma Co., Ltd.
CompletedNCT01142596
Official study titleLong-term Extension Trial of Asenapine in Subjects With Schizophrenia (Phase 3 ; Protocol No. P06125)
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 20–64
- Countries
- Sponsor
- Organon and Co
CompletedNCT01244828
Official study titleLong-term Study of Asenapine in Subjects With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (Protocol P06238)
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 20+
- Countries
- Sponsor
- Organon and Co
CompletedNCT02335658
Official study titleLong-term Study of DSP-5423P in Patients With Schizophrenia <Phase 3>
This study has finished and is no longer accepting participants.
In TokyoSchizophreniaMedication studyAges 18+
- Countries
- Japan
- Sponsor
- Sumitomo Pharma Co., Ltd.
CompletedNCT01626872
Official study titleLong-Term Extension Study of MP-214 in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including SapporoSchizophreniaMedication studyAges 20–65
- Countries
- Japan, South Korea, Taiwan
- Sponsor
- Tanabe Pharma Corporation
WithdrawnNCT05469815
Official study titleLost Children Society (LCS), Metacognitive Training Integrated Into an Online Therapeutic Tabletop Role-playing Game for Early-onset Schizophrenia Patients : a Pilot Study on Feasibility
This study was withdrawn before enrollment.
Remote / onlineSchizophreniaBehavioural studyAges 15–20
- Countries
- Sponsor
- Centre Hospitalier Departemental Vendee
CompletedNCT02175251
Official study titleLow and High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Resistant Auditory Hallucination in Schizophrenia: a Double Blind Sham-controlled Randomised Study
This study has finished and is no longer accepting participants.
In ColombesSchizophreniaInterventional studyAges 18+
- Countries
- France
- Sponsor
- Assistance Publique - Hôpitaux de Paris
SuspendedNCT05259306
Official study titleLow-Intensity Focused Ultrasound of the Mediodorsal Thalamus for Treatment-resistant Schizophrenia: Circuit Interrogation and Symptom Assessment
Recruitment is currently suspended.
In New YorkSchizophreniaDevice studyAges 21–80
- Countries
- United States
- Sponsor
- NYU Langone Health
CompletedNCT04959032
Official study titleA Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Lumateperone for the Prevention of Relapse in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–60
- Countries
- United States, Bulgaria, Poland, + 1 other
- Sponsor
- Intra-Cellular Therapies, Inc.
CompletedNCT06527885
Official study titleTreatment Satisfaction and Effectiveness of Lurasidone on Quality of Life and Functioning in Adult Patients With Schizophrenia Treated in the Real World Italian Clinical Practice
This study has finished and is no longer accepting participants.
Multiple locations, including BresciaSchizophreniaObservational studyAges 18–99
- Countries
- Italy
- Sponsor
- Aziende Chimiche Riunite Angelini Francesco S.p.A
TerminatedNCT02746965
This study ended early.
In ShanghaiSchizophreniaDevice studyAges 18–55
- Countries
- China
- Sponsor
- Shanghai Mental Health Center
CompletedNCT03007628
This study has finished and is no longer accepting participants.
In ShanghaiSchizophreniaDevice studyAges 18–55
- Countries
- China
- Sponsor
- Shanghai Mental Health Center